nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—uterine cervix—vaginal cancer	0.151	0.151	CbGeAlD
Emtricitabine—DCK—urethra—vaginal cancer	0.138	0.138	CbGeAlD
Emtricitabine—DCK—endometrium—vaginal cancer	0.136	0.136	CbGeAlD
Emtricitabine—DCK—mammalian vulva—vaginal cancer	0.132	0.132	CbGeAlD
Emtricitabine—DCK—uterus—vaginal cancer	0.126	0.126	CbGeAlD
Emtricitabine—DCK—female reproductive system—vaginal cancer	0.113	0.113	CbGeAlD
Emtricitabine—DCK—female gonad—vaginal cancer	0.103	0.103	CbGeAlD
Emtricitabine—DCK—vagina—vaginal cancer	0.102	0.102	CbGeAlD
